Medical congresses generate large amounts of information about healthcare professionals’ (HCPs) treatment preferences, clinical priorities and views on pharmaceutical brands. However, extracting useful intelligence from these conversations remains a challenge for pharmaceutical companies and healthcare advertising agencies.
Discussions take place across conference sessions, webinars, social media and research presentations, often leaving valuable information spread across unstructured sources. Manual analysis can be slow, making it difficult to identify emerging trends, assess sentiment and respond to changes in clinical priorities.
Talking Medicines addresses this through its DrugVoice platform, which uses natural language processing, machine learning and large language models to analyse healthcare professional conversations and convert them into structured intelligence.
The platform can track changes in sentiment, identify recurring themes, assess responses to brand messaging and categorise healthcare professionals according to their behaviour, language and interests. This information can help pharmaceutical marketing teams understand treatment trends, identify unmet needs and develop more relevant communications.
The technology can also be applied throughout the medical congress process. Before an event, it can help identify areas of clinical interest and inform engagement strategies. During congresses, it can monitor changes in sentiment, identify influential voices and track reactions to messaging. Following an event, the analysis can be used to assess engagement, evaluate campaign performance and identify areas where communication may need to change.
For pharmaceutical companies and agencies, this provides a way to assess how messages are received by healthcare professionals and whether communications reflect their clinical priorities.
Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.









































